Overview

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
Many women choose Depo-Provera for birth control because it is easy to use and very effective. However, a significant number of Depo-Provera users experience irregular bleeding during the first 90 days. Many users discontinue after their first injection due to irregular bleeding. This study will evaluate the effect of using an estrogen vaginal ring during the first 90 days of Depo-Provera use to see if it is acceptable to women and whether it decreases irregular bleeding during the first 90 days of use and increases continuation to a second injection.
Phase:
N/A
Details
Lead Sponsor:
Columbia University
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Medroxyprogesterone
Medroxyprogesterone Acetate
Polyestradiol phosphate